Nigel S. Watson

1.1k total citations
35 papers, 678 citations indexed

About

Nigel S. Watson is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Nigel S. Watson has authored 35 papers receiving a total of 678 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 16 papers in Pharmacology and 12 papers in Organic Chemistry. Recurrent topics in Nigel S. Watson's work include Microbial Natural Products and Biosynthesis (15 papers), Plant biochemistry and biosynthesis (13 papers) and Computational Drug Discovery Methods (7 papers). Nigel S. Watson is often cited by papers focused on Microbial Natural Products and Biosynthesis (15 papers), Plant biochemistry and biosynthesis (13 papers) and Computational Drug Discovery Methods (7 papers). Nigel S. Watson collaborates with scholars based in United Kingdom, United States and Germany. Nigel S. Watson's co-authors include Panayiotis A. Procopiou, Barry C. Ross, Julie L. Hutson, Philip J. Sidebottom, S. J. Lane, Michael Snowden, Robert J. Williams, J. Motteram, A.J. Baxter and Antonio Desmond McCarthy and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Tetrahedron Letters.

In The Last Decade

Nigel S. Watson

35 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nigel S. Watson United Kingdom 13 466 228 193 111 110 35 678
Soumya P. Sahoo United States 19 511 1.1× 153 0.7× 433 2.2× 52 0.5× 38 0.3× 31 1.1k
Barbora Orlikova Luxembourg 18 444 1.0× 244 1.1× 304 1.6× 39 0.4× 63 0.6× 23 926
Josefin Rosén Sweden 7 260 0.6× 134 0.6× 85 0.4× 135 1.2× 61 0.6× 10 460
Jane L. Wang United States 10 121 0.3× 260 1.1× 310 1.6× 95 0.9× 19 0.2× 10 535
Sandeep Jain India 14 230 0.5× 99 0.4× 134 0.7× 27 0.2× 100 0.9× 29 562
M. L. HOEFLE United States 11 259 0.6× 73 0.3× 304 1.6× 71 0.6× 43 0.4× 18 613
E.S. Hamanaka United States 10 286 0.6× 105 0.5× 165 0.9× 45 0.4× 11 0.1× 13 507
Hans Peter Märki Switzerland 14 474 1.0× 105 0.5× 182 0.9× 113 1.0× 11 0.1× 20 734
James L. Stanton Switzerland 19 424 0.9× 118 0.5× 483 2.5× 46 0.4× 15 0.1× 27 891

Countries citing papers authored by Nigel S. Watson

Since Specialization
Citations

This map shows the geographic impact of Nigel S. Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nigel S. Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nigel S. Watson more than expected).

Fields of papers citing papers by Nigel S. Watson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nigel S. Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nigel S. Watson. The network helps show where Nigel S. Watson may publish in the future.

Co-authorship network of co-authors of Nigel S. Watson

This figure shows the co-authorship network connecting the top 25 collaborators of Nigel S. Watson. A scholar is included among the top collaborators of Nigel S. Watson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nigel S. Watson. Nigel S. Watson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Needle, Saul, Cynthia L. Burns-Kurtis, Richard E. Valocik, et al.. (2008). Antithrombotic Potential of GW813893: A Novel, Orally Active, Active-site Directed Factor Xa Inhibitor. Journal of Cardiovascular Pharmacology. 52(1). 66–71. 10 indexed citations
2.
Young, Robert J., David Brown, Cynthia L. Burns-Kurtis, et al.. (2007). Selective and dual action orally active inhibitors of thrombin and factor Xa. Bioorganic & Medicinal Chemistry Letters. 17(10). 2927–2930. 16 indexed citations
3.
Senger, Stefan, Chuen Chan, M.A. Convery, et al.. (2007). Sulfonamide-related conformational effects and their importance in structure-based design. Bioorganic & Medicinal Chemistry Letters. 17(10). 2931–2934. 29 indexed citations
4.
Senger, Stefan, M.A. Convery, Chuen Chan, & Nigel S. Watson. (2006). Arylsulfonamides: A study of the relationship between activity and conformational preferences for a series of factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(22). 5731–5735. 23 indexed citations
5.
Procopiou, Panayiotis A., Brian Dymock, Graham G. A. Inglis, et al.. (1998). Novel squalestatin derivatives arising from reactions at the allylic centre of the C1-side chain. Journal of the Chemical Society Perkin Transactions 1. 327–334. 3 indexed citations
6.
Watson, Nigel S. & Panayiotis A. Procopiou. (1996). 7 Squalene Synthase Inhibitors: Their Potential as Hypocholesterolaemic Agents. Progress in medicinal chemistry. 33. 331–378. 30 indexed citations
7.
Procopiou, Panayiotis A., Brian J. Cox, Barrie E. Kirk, et al.. (1996). The Squalestatins:  Inhibitors of Squalene Synthase. Enzyme Inhibitory Activities and in Vivo Evaluation of C3-Modified Analogues. Journal of Medicinal Chemistry. 39(7). 1413–1422. 20 indexed citations
8.
Procopiou, Panayiotis A., et al.. (1995). The squalestatins: cleavage of the bicyclic core via the novel 6,8-dioxabicyclo[3.2.1]octane ring system. Journal of the Chemical Society Perkin Transactions 1. 1341–1341. 6 indexed citations
9.
Andreotti, Daniele, Panayiotis A. Procopiou, & Nigel S. Watson. (1994). The squalestatins: Cleavage of the bicyclic core via the novel 2,8,9-trioxabicyclo[3.3.1]nonane ring system. Tetrahedron Letters. 35(11). 1789–1792. 12 indexed citations
10.
Procopiou, Panayiotis A., et al.. (1993). Inhibitors of cholesterol biosynthesis. 2. 3,5-Dihydroxy-7-(N-pyrrolyl)-6-heptenoates, a novel series of HMG-CoA reductase inhibitors. Journal of Medicinal Chemistry. 36(23). 3658–3662. 24 indexed citations
11.
Watson, Nigel S., et al.. (1993). The squalestatins: potent inhibitors of squalene synthase. The role of the tricarboxylic acid moiety.. Bioorganic & Medicinal Chemistry Letters. 3(12). 2541–2546. 16 indexed citations
12.
Inglis, Graham G. A., et al.. (1993). The squalestatins: C-3 Decarboxylation studies and rearrangement to the 6,8-dioxabicyclo[3.2.1]octane ring system. Tetrahedron Letters. 34(38). 6143–6146. 12 indexed citations
13.
Procopiou, Panayiotis A., et al.. (1993). The squalestatins: novel inhibitors of squalene synthase. The optimal C1 chain-length requirements.. Bioorganic & Medicinal Chemistry Letters. 3(12). 2527–2532. 12 indexed citations
14.
Sidebottom, Philip J., et al.. (1992). The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. II. Structure elucidation.. The Journal of Antibiotics. 45(5). 648–658. 134 indexed citations
15.
Watson, Nigel S. & W D Black. (1986). Pharmacokinetic study of chloramphenicol in calves using sensitive gas-liquid chromatographic analysis.. PubMed. 50(3). 444–6. 1 indexed citations
16.
Cherry, Peter C., et al.. (1980). Conversion of clavulanic acid into thiadeoxa nuclear analogues. Tetrahedron Letters. 21(6). 561–564. 7 indexed citations
17.
Cherry, Peter C., et al.. (1978). Reactions of sulphur nucleophiles with activated derivatives of clavulanic acid. Journal of the Chemical Society Chemical Communications. 467–467. 6 indexed citations
18.
Stoodley, Richard J. & Nigel S. Watson. (1974). Studies related to penicillins. Part XIII. Transformations of methyl α-[(2R,3R)-1-(2-hydroxy-2-methylpropionyl)-4-oxo-3-phenoxyacetamidoazetidin-2-ylthio]acetate. Journal of the Chemical Society Perkin Transactions 1. 252–258. 2 indexed citations
19.
Stoodley, Richard J. & Nigel S. Watson. (1974). Studies related to penicillins. Part XIV. Oxidations of (4R,5R)-11,11-dimethyl-4-phenoxyacetamido-6-thia-2,9,10-triazatricyclo[6.3.0.02,5]-undec-8-en-3-one. Journal of the Chemical Society Perkin Transactions 1. 0(14). 1632–1632. 1 indexed citations
20.
Stoodley, Richard J. & Nigel S. Watson. (1973). Studies related to penicillins. Part X. Some transformations of 4-iso-propylidene-3-oxo-7β-phenoxyacetamidocepham. Journal of the Chemical Society Perkin Transactions 1. 19(0). 2105–2108. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Soumya P. Sahoo Breakdown of academic impact, for papers by Barbora Orlikova Breakdown of academic impact, for papers by Josefin Rosén Breakdown of academic impact, for papers by Jane L. Wang Breakdown of academic impact, for papers by Sandeep Jain Breakdown of academic impact, for papers by M. L. HOEFLE Breakdown of academic impact, for papers by E.S. Hamanaka Breakdown of academic impact, for papers by Hans Peter Märki Breakdown of academic impact, for papers by James L. Stanton
Rankless by CCL
2026